Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Founder David Schwartz Dies at 88

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories' Founder David Schwartz died on Sunday, the company announced. He was 88.

Schwartz was the president, CEO, and, chairman of the firm from 1957 until 2003 when his son, Norman Schwartz, succeeded him. He remained chairman of the company's board from 1957 until his passing.

Schwartz and his wife, Alice Schwartz, founded Bio-Rad in 1952 in Berkeley, Calif. after both graduated from the University of California, Berkeley. Originally, the firm developed and produced chemicals used in biochemical, pharmaceutical, and other life science research applications, and expanded into the clinical diagnostics field in the 1960s when it developed its first test kit for thyroid function based on separation methods and materials developed for life science research.

Today, Bio-Rad, headquartered in Hercules, Calif., has about 7,000 employees. In 2011 it posted $2.07 billion in revenues.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.